FDA.reportPublic FDA data

CANAGLIFLOZIN - Food and Drug Administration

Set ID
bfd158f9-2ca9-be9c-cd97-e30d4086e4ad
Type
Indexing - Product Concept
Effective date
2014-05-08
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameA-S Medication Solutions2026-09-21
These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014Product nameJanssen Pharmaceuticals, Inc. | Janssen Pharmaceuticals Inc | Patheon Puerto Rico, Inc. | PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH | Janssen Pharmaceutica NV | Ajinomoto OmniChem | Farmhispania | Rolabo Outsourcing S.L. (Spain) | Janssen Cilag SpA | Johnson & Johnson Private Limited (Mumbai) | Janssen Ortho LLC | Granules India Limited2026-08-24
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameJanssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Ajinomoto OmniChem | Janssen Pharmaceutica NV | Janssen Cilag SpA | Janssen-Ortho LLC2026-06-11
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameCardinal Health 107, LLC2026-02-17
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameCardinal Health 107, LLC2026-01-26
These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014Product nameJanssen Pharmaceuticals, Inc. | Janssen Pharmaceuticals Inc | Patheon Puerto Rico, Inc. | PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH | Janssen Pharmaceutica NV | Ajinomoto OmniChem | Farmhispania | Rolabo Outsourcing S.L. (Spain) | Janssen Cilag SpA | Johnson & Johnson Private Limited (Mumbai) | Janssen Ortho LLC | Granules India Limited2025-08-21
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameJanssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Ajinomoto OmniChem | Janssen Pharmaceutica NV | Janssen Cilag SpA | Janssen-Ortho LLC2025-03-20
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameA-S Medication Solutions2023-12-15
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameA-S Medication Solutions2023-12-15
These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013Product nameA-S Medication Solutions2023-10-24